查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1450296

脈衝場消融（PFA）系統市場：現況分析與預測（2023-2030）

Pulsed Field Ablation (PFA) System Market: Current Analysis and Forecast (2023-2030)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 158 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

由於更容易罹患心臟病的老年人口的增加，脈衝場消融（PFA）系統市場預計將穩定成長約25.1%。 例如，2022年10月，世界衛生組織（WHO）宣布，到2050年，全球60歲以上人口將翻一番，達到21億。 2020 年至 2050 年間，80 歲及以上的人口數量預計將增加兩倍，達到 4.26 億。 在預測期內，有幾個因素正在推動市場成長，例如心臟病和呼吸系統疾病盛行率的急劇上升、對心血管疾病的認識不斷提高以及對心臟病學的投資增加。 除此之外，透過脈衝場消融（PFA）系統提高治療效率可以加快治療過程並提高準確性，這也穩步推動了脈衝場消融（PFA）系統市場的發展。

市場依治療領域分為心血管疾病、腫瘤疾病、呼吸系統疾病等。 由於越來越多的老年人更容易患心房顫動等心臟病，心血管疾病領域將在 2022 年在全球脈衝場消融 (PFA) 系統市場中佔據最大份額。 例如，根據美國國立衛生研究院2023年8月的數據，心房顫動的盛行率隨著年齡的增長而增加，65歲以上的人中有5%、80歲以上的人有10%患有此病。據說確實有。 由於對微創手術的需求不斷增加，該市場已顯著成長。 心臟病家族史也是該細分市場的驅動因素。 因此，在治療領域中，心血管疾病領域將在2022年佔據很大的市場。

依產品組成，市場分為導管和產生器。 由於發電機提供的能源供應精度較高，預計發電機產業在預測期內將佔據較大份額。 例如，2024 年 1 月，波士頓科學公司的 FARAPULSE 現場消融 (PFA) 系統獲得美國食品藥物管理局 (FDA) 批准。 FARAPULSE 現場消融 (PFA) 系統配備了名為 FARASTAR PFA 產生器的先進發生器。 發生器是 PFA 系統的重要組成部分，因為它產生組織消融所需的脈衝電場。 發電機技術的進步，例如增強的控制機制和改進的安全功能，有助於在各種醫療程序中更多地採用 PFA 系統。 此外，PFA技術的應用正在從心血管疾病擴展到癌症和神經系統疾病等其他疾病，從而推動了對更先進和多功能發電機的需求。 因此，在產品組件中，發電機類別預計在預測期內呈現高複合年增長率。

根據應用，市場分為消融和消融測繪。 2022年，消融細分市場在細分市場中佔據最大份額。 PFA 的優點，例如提高精確度、減少對周圍組織的附帶損傷以及縮短手術時間，正在推動 PFA 系統消融市場的擴張。 因此，在2022年的市場中，消融領域將在應用領域中佔有較大份額。

為了更了解脈衝場消融 (PFA) 系統的市場實施情況，我們根據其在北美、歐洲、亞太地區和世界其他地區的全球影響力對市場進行了分析。 預計在預測期內，亞太地區全球脈衝場消融 (PFA) 系統市場將以高複合年增長率成長。 許多亞太國家的人口老化，加上生活方式因素，正在增加心律不整和其他可以使用 PFA 系統治療的疾病的盛行率。 其他幾個因素，例如各種脈衝場消融（PFA）系統的市場發展激增、可及性的提高以及醫療保健成本的多樣化，正在推動預測期內的市場成長。 該地區正在實施一項關於心血管疾病的重大宣傳計劃。 例如，SEAHEARTS（WHO HEARTS一攬子計畫在東南亞地區的改編版）與2023年世界心臟日的主題 "使用心臟，了解心臟" 產生共鳴，並為各國提供了改善心臟病現狀的路線圖。 因此，預計亞太地區在預測期內將表現出更高的複合年增長率。

市場上營運的主要公司包括 Boston Scientific Corporation、Kardium、Abbott、Galvanize Therapeutics, Inc.、MIRAI MEDICAL、Pulse Biosciences, Inc.、AccuPulse Medical、Acutus Medical, Inc. 和 CathRx Ltd.、AccuPulse Medical、和更多。

目錄

第1章市場介紹

  • 市場定義
  • 主要目標
  • 利害關係人
  • 限制

第2章研究方法或前提

  • 調查過程
  • 調查方法
  • 受訪者簡介

第3章市場總結

第 4 章執行摘要

第 5 章 COVID-19 對脈衝場消融 (PFA) 系統市場的影響

第 6 章脈衝場消融 (PFA) 系統市場收入（2020-2030 年）

第 7 章市場洞察：依治療領域

  • 心血管疾病
  • 腫瘤疾病
  • 呼吸系統疾病
  • 其他

第 8 章市場洞察：按產品組件

  • 導管
  • 發電機

第 9 章市場洞察：按應用劃分

  • 消融
  • 消融和映射

第 10 章市場洞察：按地區

  • 北美
    • 美國
    • 加拿大
    • 北美其他地區
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 亞太地區其他地區
  • 世界其他地區

第 11 章脈衝場消融 (PFA) 系統市場動態

  • 市場驅動因素
  • 市場挑戰
  • 影響分析

第 12 章脈衝場消融 (PFA) 系統市場機會

第 13 章脈衝場消融 (PFA) 系統市場趨勢

第14章需求面與供給面分析

  • 需求方分析
  • 供給面分析

第 15 章價值鏈分析

第16章競爭場景

  • 競爭狀況
    • 波特五力分析

第17章公司簡介

  • Boston Scientific Corporation
  • Kardium
  • Abbott
  • Galvanize Therapeutics, Inc.
  • MIRAI MEDICAL
  • Pulse Biosciences, Inc.
  • AccuPulse Medical
  • Acutus Medical, Inc.
  • CathRx Ltd.
  • AccuPulse Medical

第18章 免責事項

簡介目錄
Product Code: UMHE212630

Pulsed field ablation (PFA) system is an innovative medical technology used for the treatment of various cardiac arrhythmias and other medical conditions. Unlike traditional ablation techniques that use thermal energy to create lesions on target tissues, PFA relies on the delivery of pulsed electric fields to achieve tissue ablation. The introduction of PFA systems represents a significant advancement in the field of electrophysiology and minimally invasive procedures. The pulsed field ablation (PFA) system has been gaining traction in the market due to several factors, such as increasing incidence of atrial fibrillation, advancements in technology, growing minimally invasive procedures, increasing awareness and diagnosis, rising healthcare expenditure, rising regulatory support, and surge in company collaborations & partnerships are leading drivers of pulsed field ablation (PFA) systems globally.

The Pulsed Field Ablation (PFA) Systems Market is expected to grow at a steady rate of around 25.1% owing to the rising geriatric population which is more prone to heart disorders. For instance, in October 2022, according to the World Health Organization, by 2050, the world's population of people aged 60 years and older will double to 2.1 billion. The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million. Several factors, including a surge in the incidence of cardiac and respiratory disorders, increasing awareness regarding cardiovascular disorders, and increased investments in cardiology departments are driving the growth of the market during the forecast period. Apart from this, accelerated treatment efficiency with pulsed field ablation (PFA) systems has resulted in faster treatment procedures and better accuracy which is also driving this market of pulsed field ablation (PFA) systems at a steady rate.

Based on therapeutic areas, the market is segmented into cardiovascular disorders, oncological disorders, respiratory disorders, and others. The cardiovascular disorders segment held the maximum share in the global market of pulsed field ablation (PFA) systems in 2022 owing to the rising geriatric population which is more prone to heart disorders like atrial fibrillation. For instance, in August 2023, according to the National Institutes of Health, the prevalence of atrial fibrillation increases with age, with 5% of individuals over the age of 65 and 10% of those over the age of 80 having this condition. The market experienced significant growth due to the increasing demand for minimally invasive procedures. A family history of heart disease is also a propelling factor for this segment. Thus, among the therapeutic areas, the cardiovascular disorders segment held a significant share of the market in 2022.

Based on product components, the market is bifurcated into catheters and generators. The generators segment is expected to hold a significant share of the market in the forecast period owing to the better energy delivery precision by generators. For instance, in January 2024, Boston Scientific Corporation received U.S. Food and Drug Administration (FDA) approval for the FARAPULSE Field Ablation (PFA) System which has an advanced generator named FARASTAR PFA Generator which is designed for an easy three-button click to prepare, confirm and deliver therapy using bipolar & biphasic waveforms with proprietary pulses. Generators are essential components of PFA systems as they produce the pulsed electric fields required for tissue ablation. The advancements in generator technology, such as enhanced control mechanisms, and improved safety features, have contributed to the growing adoption of PFA systems for various medical procedures. Additionally, the expanding applications of PFA technology beyond cardiovascular diseases to other conditions such as cancer and neurological disorders have driven the demand for more advanced and versatile generators. Thus, amongst product components, the generators category is expected to witness a higher CAGR during the forecast period.

Based on the application area, the market is bifurcated into ablation and ablation & mapping. The ablation segment held the maximum share in the global market of pulsed field ablation (PFA) systems in 2022 owing to the desired controlled ablation provided by the device. The advantages of PFA such as improved precision, reduced collateral damage to surrounding tissues, and potentially shorter procedure times, have fueled the expansion of the ablation segment within the PFA system market. Thus, among the application areas, the ablation segment held a significant share of the market in 2022.

For a better understanding of the market adoption of pulsed field ablation (PFA) systems, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. APAC is expected to grow with a high CAGR in the global pulsed field ablation (PFA) system market in the forecast period. The aging population in many APAC countries, combined with lifestyle factors, has resulted in a higher prevalence of cardiac arrhythmias and other conditions that can be treated using PFA systems. Several other factors such as a surge in the development of a wide range of pulsed field ablation (PFA) systems, enhanced accessibility, and diversified healthcare costs are driving the market's growth during the forecast period. There have been major awareness programs regarding cardiovascular disorders in the region. For instance, SEAHEARTS (WHO HEARTS package adaptation to South-East Asia Region) resonated with the World Heart Day 2023 theme 'Use Heart, Know Heart' and offered countries a roadmap to scale up their current situations of heart disorders. Thus, APAC is expected to witness a higher CAGR during the forecast period.

Some of the major players operating in the market include Boston Scientific Corporation; Kardium; Abbott; Galvanize Therapeutics, Inc.; MIRAI MEDICAL; Pulse Biosciences, Inc.; AccuPulse Medical; Acutus Medical, Inc.; CathRx Ltd.; AccuPulse Medical.

TABLE OF CONTENTS

1. MARKET INTRODUCTION

  • 1.1.Market Definitions
  • 1.2.Main Objective
  • 1.3.Stakeholders
  • 1.4.Limitation

2. RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1.Research Process of the Pulsed Field Ablation (PFA) System Market
  • 2.2.Research Methodology of the Pulsed Field Ablation (PFA) System Market
  • 2.3.Respondent Profile

3. MARKET SYNOPSIS

4. EXECUTIVE SUMMARY

5. IMPACT OF COVID-19 ON THE PULSED FIELD ABLATION (PFA) SYSTEM MARKET

6. PULSED FIELD ABLATION (PFA) SYSTEM MARKET REVENUE (USD BN), 2020-2030F

7. MARKET INSIGHTS BY THERAPEUTIC AREA

  • 7.1.Cardiovascular Disorders
  • 7.2.Oncological Disorders
  • 7.3.Respiratory Disorders
  • 7.4.Others

8. MARKET INSIGHTS BY PRODUCT COMPONENTS

  • 8.1.Catheter
  • 8.2.Generator

9. MARKET INSIGHTS BY APPLICATION AREA

  • 9.1.Ablation
  • 9.2.Ablation & Mapping

10. MARKET INSIGHTS BY REGION

  • 10.1.North America
    • 10.1.1.U.S.
    • 10.1.2.Canada
    • 10.1.3.Rest of North America
  • 10.2.Europe
    • 10.2.1.Germany
    • 10.2.2.U.K.
    • 10.2.3.France
    • 10.2.4.Italy
    • 10.2.5.Spain
    • 10.2.6.Rest of Europe
  • 10.3.Asia-Pacific
    • 10.3.1.China
    • 10.3.2.Japan
    • 10.3.3.India
    • 10.3.4.Rest of Asia-Pacific
  • 10.4.Rest of World

11. PULSED FIELD ABLATION (PFA) SYSTEM MARKET DYNAMICS

  • 11.1.Market Drivers
  • 11.2.Market Challenges
  • 11.3.Impact Analysis

12. PULSED FIELD ABLATION (PFA) SYSTEM MARKET OPPORTUNITIES

13. PULSED FIELD ABLATION (PFA) SYSTEM MARKET TRENDS

14. DEMAND AND SUPPLY-SIDE ANALYSIS

  • 14.1.Demand Side Analysis
  • 14.2.Supply Side Analysis

15. VALUE CHAIN ANALYSIS

16. COMPETITIVE SCENARIO

  • 16.1.Competitive Landscape
    • 16.1.1.Porters Fiver Forces Analysis

17. COMPANY PROFILED

  • 17.1.Boston Scientific Corporation
  • 17.2.Kardium
  • 17.3.Abbott
  • 17.4.Galvanize Therapeutics, Inc.
  • 17.5.MIRAI MEDICAL
  • 17.6.Pulse Biosciences, Inc.
  • 17.7.AccuPulse Medical
  • 17.8.Acutus Medical, Inc.
  • 17.9.CathRx Ltd.
  • 17.10.AccuPulse Medical

18. DISCLAIMER